University of Alberta

Dr. Frank van Landeghem

Associate Professor

Department of Laboratory Medicine & Pathology

Office Phone Number: (780) 224-7515
vanlande@ualberta.ca

Contact details are for academic matters only.

About Me

Dr. Frank van Landeghem is currently appointed as Associate Professor in the Department of Laboratory Medicine & Pathology in the Faculty of Medicine and Dentistry.

Research Keywords

Biomarkers, Biomedical research, Neuro-Oncology, Translational research

- Inflammasome Activation in Glioblastoma Multiforme.
- Author(s): Erin Balcom, William Branton, Ken Petruk, Matt Wheatley, Frank van Landeghem and Christopher Power
- Volume: 88
- Issue: 16 Supplement
- Page(s): P1.172
- Publication Year: 2017
- Is Ganglioglioma A CNS Tumor With Arrested Development?
- Author(s): David Eisenstat, Frank van Landeghem
- Volume: 18
- Issue: Suppl. 6
- Page(s): vi116
- Publication Year: 2017
- Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.
- Author(s): Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DT, Luu B, Cavalli FM, Aldape K, Remke M, Mynarek M, Rutkowski S, Gururangan S, McLendon RE, Lipp ES, Dunham C, Hukin J, Eisenstat DD, Fulton D, van Landeghem FK, Santi M, van Veelen ML, Van Meir EG, Osuka S, Fan X, Muraszko KM, Tirapelli DP, Oba-Shinjo SM, Marie SK, Carlotti CG, Lee JY, Rao AA, Giannini C, Faria CC, Nunes S, Mora J, Hamilton RL, Hauser P, Jabado N, Petrecca K, Jung S, Massimi L, Zollo M, Cinalli G, Bognár L, Klekner A, Hortobágyi T, Leary S, Ermoian RP, Olson JM, Leonard JR, Gardner C, Grajkowska WA, Chambless LB, Cain J, Eberhart CG, Ahsan S, Massimino M, Giangaspero F, Buttarelli FR, Packer RJ, Emery L, Yong WH, Soto H, Liau LM, Everson R, Grossbach A, Shalaby T, Grotzer M, Karajannis MA, Zagzag D, Wheeler H, von Hoff K, Alonso MM, Tuñon T, Schüller U, Zitterbart K, Sterba J, Chan JA, Guzman M, Elbabaa SK, Colman H, Dhall G, Fisher PG, Fouladi M, Gajjar A, Goldman S, Hwang E, Kool M, Ladha H, Vera-Bolanos E, Wani K, Lieberman F, Mikkelsen T, Omuro AM, Pollack IF, Prados M, Robins HI, Soffietti R, Wu J, Metellus P, Tabori U, Bartels U, Bouffet E, Hawkins CE, Rutka JT, Dirks P, Pfister SM, Merchant TE, Gilbert MR, Armstrong TS, Korshunov A, Ellison DW, Taylor MD,
- Journal: J Clin Oncol
- Volume: 34
- Issue: 21
- Page(s): 2468-77
- Publication Year: 2017
- PMID: 27269943
- Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.
- Author(s): Hasselblatt M, Thomas C, Hovestadt V, Schrimpf D, Johann P, Bens S, Oyen F, Peetz-Dienhart S, Crede Y, Wefers A, Vogel H, Riemenschneider MJ, Antonelli M, Giangaspero F, Bernardo MC, Giannini C, Ud Din N, Perry A, Keyvani K, van Landeghem F, Sumerauer D, Hauser P, Capper D, Korshunov A, Jones DT, Pfister SM, Schneppenheim R, Siebert R, Frühwald MC, Kool M,
- Journal: Acta Neuropathol
- Volume: 132
- Issue: 1
- Page(s): 149-51
- Publication Year: 2017
- PMID: 27067307

Faculty Members

Dr. Frank van Landeghem

Associate Professor

Department of Laboratory Medicine & Pathology

About Me

Research Keywords

Inflammasome Activation in Glioblastoma Multiforme.

Is Ganglioglioma A CNS Tumor With Arrested Development?

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.

Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.